Clinical Trial Update: Fimasartan Achieving SBP Target (FAST) Study [Phase 4]

View source ↗

Summary

A Phase 4 trial (FAST) of fimasartan completed, reporting achievement of systolic blood pressure target in patients with essential hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Kanarb (Fimasartan)

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Essential,Hypertension | Phase 4 | Status: COMPLETED